Related Experiment Video

Updated: Jun 6, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Waldenström macroglobulinemia: is newer really better?

Morie A Gertz1

  • 1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA. gertz.morie@mayo.edu

Leukemia & Lymphoma
|November 12, 2010
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Related Experiment Videos

Last Updated: Jun 6, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Articles linked to this work by shared authors, journal, and citation graph.

Advances in the treatment of hereditary transthyretin amyloidosis: A review.

Brain and behavior·2019

The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors.

Acta haematologica·2019

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern.

British journal of haematology·2019

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.

American journal of hematology·2019

Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis.

Expert review of clinical pharmacology·2019

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis.

American journal of hematology·2019

Effects of O-GlcNAc glycosylated modified transferase on prognosis of diffuse large B-cell lymphoma and analysis of downstream targets.

Leukemia & lymphoma·2026

Additional myelodysplasia-related gene mutations alter clinical presentation and worsen prognosis in patients with SRSF/TET2 co-mutated myeloid neoplasms.

Leukemia & lymphoma·2026

Efficacy and tolerability of venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukemia - real-world analysis of Polish adult leukemia study group.

Leukemia & lymphoma·2026

Prognostic significance of baseline liver enzyme patterns in chronic lymphocytic leukemia: a nationwide real-world cohort study.

Leukemia & lymphoma·2026

A phase II study of low dose melphalan with thiotepa and fludarabine as preparative regimen for alternative donor transplantation.

Leukemia & lymphoma·2026

Multimorbidity patterns and survival outcomes in older adults with multiple myeloma: findings from SEER-Medicare.

Leukemia & lymphoma·2026

Secondary Staphylococcus capitis Infection of a Long-Standing Non-Coronary Sinus of Valsalva-to-Right Atrial Fistula Initially Misdiagnosed as a Gerbode Defect: A Case Report.

Journal of clinical medicine·2026

Retraction notice to "Mathematical modeling and QSPR analysis of hepatitis treatment drugs through connection indices an innovative approach" [Heliyon 11 (2025) e41234].

Heliyon·2026

Retraction notice to "The gingival crevicular fluid biomarkers with micropulse vibration device: A pilot study" [Heliyon 10 (2024) e31982].

Heliyon·2026

Retraction notice to "A review on surface modification of nanofibrous textiles for diverse applications: Focus on medical uses" [Heliyon 11 (2025) e41863].

Heliyon·2026

Moraxella nonliquefaciens Keratitis Due to Ocular Surface Disease in a Patient Treated with Zanubrutinib for Mantle Cell Lymphoma.

Eye & contact lens·2026

Retraction notice to "Rapid cutaneous remission response to tofacitinib and systemic corticosteroids in VEXAS syndrome with a novel UBA1 mutation" [JAAD Case Reports 68 (2026) 105-107].

JAAD case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us